RecruitingNot Applicable

Artificial Intelligence in Colonoscopy

Poland630 participantsStarted 2024-11-01

Plain-language summary

Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination. This study aims to evaluate the impact of artificial intelligence on the detection rate of polyps and early stages of colorectal cancer.

Who can participate

Age range50 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Consent to participate in the study, * Age between 50 and 65 years, * Scheduled outpatient colonoscopy. Exclusion Criteria: * Previous colonoscopy, * History of colorectal surgery, * Ongoing biological therapy for any indication, * Primary sclerosing cholangitis, * Familial polyposis syndrome, * Chronic diarrhea, * Ulcerative colitis, * Crohn's disease.

What they're measuring

Adenoma detection rate (ADR)

Timeframe: During the colonoscopy examination

Trial details

NCT IDNCT06786793

SponsorJagiellonian University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-31

Contact for this trial

Zofia Orzeszko, MD

+48123797145 z.orzeszko@bonifratrzy.krakow.pl

View on ClinicalTrials.gov More Quality Indicators, Health Care trials